Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

NCT01358825 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus
Poliomyelitis
Haemophilus Influenzae Type b
Acellular Pertussis
Diphtheria
Hepatitis B
Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Interventions

PROCEDURE: Blood Sampling

Sponsor

GlaxoSmithKline